FDA Drug Application (202524) for LEVETIRACETAM by ROUSES POINT PHARMS

Back to FDA Applications sponsored by ROUSES POINT PHARMS

Application Number202524
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage500MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLEVETIRACETAM
Active IngredientLEVETIRACETAM

Active IngredientCount
List of drugs with Active Ingredient LEVETIRACETAM5


Back to FDA Applications sponsored by ROUSES POINT PHARMS